OMEZA Holdings Announces an Exclusive Licensing Agreement with Hikma in Select MENA Markets

PartnershipOCM™Positive

AI Analysis

Summary

OMEZA Holdings has signed an exclusive licensing agreement with Hikma Pharmaceuticals for OCM™ in select MENA markets, granting Hikma distribution rights to the OMEZA product in the region.

Outcome Details

Exclusive licensing agreement signed for select MENA markets

Importance:6/10

Sentiment:

0.60

licensingpartnershipMENAexclusive agreementregional expansion

Related Companies

$HIK.L

Read the original article

Published by PR Newswire Pharma on September 21, 2026 11:00 AM

Read Original